We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Cost Analysis of Interstim Therapy

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00200031
First Posted: September 20, 2005
Last Update Posted: July 28, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
MedtronicNeuro
September 12, 2005
September 20, 2005
July 28, 2008
July 2005
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00200031 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
A Cost Analysis of Interstim Therapy
Interstim Therapy Retrospective Cost Analysis and Quality of Life
A study to examine the impact that Interstim Therapy for Urinary Control has on health care utilization and costs within a health care system and the satisfaction with treatment expressed by patients using this therapy.
A retrospective administrative data analysis combined with a prospective health related quality of life/satisfaction with treatment survey designed to examine the impact that Interstim Therapy for Urinary Control has had on health care utilization and costs for the Kaiser Permanente system and the satisfaction with treatment expressed by patients using this therapy.
Observational
Not Provided
Not Provided
Not Provided
Not Provided
Not Provided
Urinary Retention and Symptoms of Overactive Bladder (Urge, Frequency)
Device: Interstim therapy
Not Provided
Aboseif SR, Kim DH, Rieder JM, Rhee EY, Menefee SA, Kaswick JR, Ree MH. Sacral neuromodulation: cost considerations and clinical benefits. Urology. 2007 Dec;70(6):1069-73; discussion 1073-4.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
150
April 2006
Not Provided
Patients implanted with an Interstim Therapy for Urinary Control or undergoing test stimulation for potential placement of Interstim Therapy during the period of June 1, 2002 through June 30, 2004 and who are enrolled with Kaiser-Permanente of Southern California.
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
Not Provided
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00200031
4348
Not Provided
Not Provided
Not Provided
Not Provided
MedtronicNeuro
Not Provided
Principal Investigator: Sherif Aboseif, MD Kaiser Permanente
MedtronicNeuro
July 2008